NCCN Nursing Program: Role of the Advanced Practice Nurse in Quality Oncology Care CE

Denise Reinke, APRN, BC, AOCN; Barbara Rogers, MN, AOCN, CRNP, ANP-BC Author Information and Disclosures

Release Date: May 9, 2008; Valid for credit through May 9, 2009

Credits Available
Nurses - 1.5 ANCC contact hours

Selected presentations from the NCCN 2008 Nursing Program: Role of the Advanced Practice Nurse in Quality Oncology Care™ held in Hollywood, Florida. This activity is designed to be completed within approximately 90 minutes.

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the educational content; (3) take the post-test and complete the evaluation; (4) view/print certificate View details.

Contents of This CE Activity

  1. Stay Connected: Update on the Management of SarcomaDenise Reinke, APRN, BC, AOCNAvailable As: Slides/Audio | Slides/Transcript | Audio
  2. Managing Effects of Cancer Therapy: Nausea and VomitingBarbara Rogers, MN, AOCN, CRNP, ANP-BCAvailable As: Slides/Audio | Slides/Transcript | Audio

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 National Comprehensive Cancer Network
Amgen, Eisei, Lilly, Endo, Merck, MGI, Novartis, Pfizer
Learning Objectives
Following this activity, participants should be able to:
  • Identify the types of sarcoma and respective diagnostic considerations
  • Provide examples of current treatment modalities for the management of sarcoma
  • Recognize the patient population at risk for chemotherapy-induced nausea and vomiting
  • Summarize current treatment strategies for managing chemotherapy-induced nausea and vomiting
Author Disclosures
Denise Reinke, APRN, BC, AOCN
Oncology Nurse Practitioner, University of Michigan Comprehensive Cancer Center; Ann Arbor, Michigan

Disclosure: Ms. Reinke has disclosed that she has no financial interests, arrangements, or affiliations with the manufacturer of any products or devices to be discussed in this activity or who may financially support the activity.

Ms. Reinke has indicated that her presentation will not include discussion of investigational or unlabeled uses of commercial products.

Barbara Rogers, MN, AOCN, CRNP, ANP-BC
Adult Hematology Oncology Nurse Practitioner, Fox Chase Cancer Center; Philadelphia, Pennsylvania

Disclosure: Ms. Rogers has disclosed that she has financial interests, arrangements, or affiliations with the manufacturer of products or devices to be discussed in this activity or who may financially support the activity. She has served on the product/speakers' bureau for Celgene Corporation; Genentech, Inc.; and Solvay Pharmaceuticals.

Ms. Rogers has indicated that her presentation will include discussion of investigational or unlabeled uses of commercial products.
 
National Comprehensive Cancer Network
This activity is approved for 1.5 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

More Activities from NCCN

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.